Rohit Loomba

Dr. Rohit Loomba is a Professor of Medicine (with tenure), Director of Hepatology, at University of California at San Diego. He is an internationally recognized thought leader in the management of nonalcoholic fatty liver disease and has established a thriving and vibrant center for clinical and research in NAFLD at UCSD. Dr. Loomba is the founding director of the UCSD NAFLD Research Center. Along with his collaborators, he has led several innovative applications such as establishment of MRI-PDFF as a non-invasive biomarker of treatment response in early phase trials in NASH, which has now been adopted in more than 50 clinical trials conducted worldwide. He holds two patents on non-invasive biomarkers of NAFLD and fibrosis.His research is funded by the National Institutes of Health including R01, U01, P30 and P01 grant mechanisms, Foundation of NIH, National Science Foundation as well as several investigator initiated research projects funded by the industry. He is the Principal Investigator, UCSD, for the NIDDK-sponsored NASH Clinical Research Network. He served as the elected Chair of the NAFLD, Special Interest Group of the American Association for the Study of Liver Diseases. And is the elected member to the National Board of Directors of the American Liver Foundation.He serves on the Editorial Board of Gastroenterology, Journal of Hepatology, GUT and Nature Reviews in Gastroenterology and Hepatology. He served as the Deputy Editor of HEPATOLOGY, the official journal of the AASLD, from 2017-2021.Dr. Loomba has published more than 300 manuscripts and has an H-index of 87. He is among the top 1% of the globally highly cited scientists across all fields in 2019 and 2020 by Web of Science. He is an elected member of American Society of Clinical Investigation. UCSD Gastroenterology and Hepatology were listed as the number 1 research and education program in the World by the US World News ranking in 2020.